The Food Allergy drugs in development market research report provides comprehensive information on the therapeutics under development for Food Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Food Allergy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Food Allergy - Drugs In Development, 2023

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Food Allergy and features dormant and discontinued products.

GlobalData tracks 85 drugs in development for Food Allergy by 68 companies/universities/institutes. The top development phase for Food Allergy is preclinical with 35 drugs in that stage. The Food Allergy pipeline has 76 drugs in development by companies and nine by universities/ institutes. Some of the companies in the Food Allergy pipeline products market are: IgGenix, Allero Therapeutics and Aimmune Therapeutics.

The key targets in the Food Allergy pipeline products market include Immunoglobulin E (IgE) , Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R), and Toll Like Receptor 4 (hToll or CD284 or TLR4).

The key mechanisms of action in the Food Allergy pipeline product include Immunoglobulin E (IgE) Inhibitor with five drugs in Phase III. The Food Allergy pipeline products include 12 routes of administration with the top ROA being Oral and 15 key molecule types in the Food Allergy pipeline products market including Allergenics (Allergen), and Monoclonal Antibody.

Food Allergy overview

Food allergies are immune system reactions to certain proteins in food. Symptoms range from mild itching to severe anaphylaxis, involving difficulty breathing and a drop in blood pressure, which can be life-threatening. Common allergens include peanuts, tree nuts, shellfish, eggs, milk, wheat, and soy. Strict avoidance and preparedness for accidental exposure are crucial. Diagnosis involves tests like skin prick or blood tests, and management typically includes eliminating the allergen, carrying emergency medication (like epinephrine), and vigilant label reading. Seeking medical advice is crucial for proper diagnosis, management, and to create an emergency action plan.

For a complete picture of Food Allergy’s pipeline drug market, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.